留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

肺移植免疫学相关基础与临床研究进展

肖漓 解立新 石炳毅

肖漓, 解立新, 石炳毅. 肺移植免疫学相关基础与临床研究进展[J]. 器官移植, 2021, 12(6): 637-642. doi: 10.3969/j.issn.1674-7445.2021.06.001
引用本文: 肖漓, 解立新, 石炳毅. 肺移植免疫学相关基础与临床研究进展[J]. 器官移植, 2021, 12(6): 637-642. doi: 10.3969/j.issn.1674-7445.2021.06.001
Xiao Li, Xie Lixin, Shi Bingyi. Progress on basic and clinical research of immunology in lung transplantation[J]. ORGAN TRANSPLANTATION, 2021, 12(6): 637-642. doi: 10.3969/j.issn.1674-7445.2021.06.001
Citation: Xiao Li, Xie Lixin, Shi Bingyi. Progress on basic and clinical research of immunology in lung transplantation[J]. ORGAN TRANSPLANTATION, 2021, 12(6): 637-642. doi: 10.3969/j.issn.1674-7445.2021.06.001

肺移植免疫学相关基础与临床研究进展

doi: 10.3969/j.issn.1674-7445.2021.06.001
基金项目: 

国家自然科学基金 81571555

详细信息
    作者简介:

    石炳毅,主任医师、教授、博士研究生导师,全国政协委员、国务院政府特殊津贴获得者。现任中国人民解放军总医院第八医学中心特聘教授、中国人体器官捐献与移植委员会委员、国家卫生健康委员会肾脏移植质量控制中心主任。兼任中华医学会器官移植学分会主任委员、中国研究型医院学会移植医学专业委员会主任委员。先后承担国家科技支撑重大项目、全军科技攻关课题等项目30余项。以第一完成人获国家科技进步二等奖1项,中华医学科技一等奖2项,获国家发明专利7项,获何梁何利科技进步奖和中国医师奖。主持建立“国家卫健委肾脏移植质量控制中心”“中国肾移植科学登记系统”等国家重点工程。主编国内行业标准《中国器官移植临床诊疗指南(2010、2017版)》和《中国器官移植临床技术操作规范(2010、2020版)》等专著10部,发表论文360余篇,其中中文核心期刊论文280篇,SCI收录期刊论文61篇,培养研究生77人

    通讯作者:

    石炳毅,Email: shibingyi666@126.com

  • 中图分类号: R617, R392

Progress on basic and clinical research of immunology in lung transplantation

More Information
  • 摘要: 器官移植受者的生存质量与免疫状态密切相关。与其他实体器官移植相比,肺移植受者的长期预后较差,其涉及的免疫学机制更为复杂,既有共性又有特性。因此,深入了解同种异体肺移植免疫应答过程中的免疫学机制对于改善肺移植受者的长期生存尤为重要。本文从肺脏免疫细胞组成的独特性、肺移植术后排斥反应特点、肺移植病原体感染的早期预警和鉴别诊断以及肺移植相关并发症等方面进行探讨,总结同种异体肺移植涉及免疫学相关的临床诊断和基础研究进展,旨在阐述肺移植的免疫学特点,为临床提高肺移植受者的长期生存率以及移植物失功的防治水平等提供理论依据。

     

  • [1] CHAMBERS DC, CHERIKH WS, HARHAY MO, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult lung and heart-lung transplantation report-2019; focus theme: donor and recipient size match[J]. J Heart Lung Transplant, 2019, 38(10): 1042- 1055. DOI: 10.1016/j.healun.2019.08.001.
    [2] BENZIMRA M, CALLIGARO GL, GLANVILLE AR. Acute rejection[J]. J Thorac Dis, 2017, 9(12): 5440-5457. DOI: 10.21037/jtd.2017.11.83.
    [3] LEI YM, CHEN L, WANG Y, et al. The composition of the microbiota modulates allograft rejection[J]. J Clin Invest, 2016, 126(7): 2736-2744. DOI: 10.1172/JCI85295.
    [4] 白丽, 王佳, 田志刚, 等. 我国在组织器官区域免疫特性与疾病领域的研究进展[J]. 中国科学(生命科学), 2019, 49(3): 220-227. https://www.cnki.com.cn/Article/CJFDTOTAL-JCXK201903003.htm

    BAI L, WANG J, TIAN ZG, et al. Research progress in tissue/organ regional immunity and diseases in China[J]. Sci China Life Sci, 2019, 49(3): 220-227. https://www.cnki.com.cn/Article/CJFDTOTAL-JCXK201903003.htm
    [5] BRACIALE TJ, SUN J, KIM TS. Regulating the adaptive immune response to respiratory virus infection[J]. Nat Rev Immunol, 2012, 12(4): 295-305.
    [6] 洪文娟, 洪志鹏. 肺移植免疫相关的研究进展及展望[J/CD]. 中华肺部疾病杂志(电子版), 2018, 11(5): 519- 523. 10.3877/cma.j.issn.1674-6902.2018.05.001

    HONG WJ, HONG ZP. Progress and prospect of immunological research on lung transplantation[J/CD]. Chin J Lung Dis (Electr Edit), 2018, 11(5): 519-523. 10.3877/cma.j.issn.1674-6902.2018.05.001
    [7] HACHEM RR, KHALIFAH AP, CHAKINALA MM, et al. The significance of a single episode of minimal acute rejection after lung transplantation[J]. Transplantation, 2005, 80(10): 1406-1413. DOI: 10.1097/01.tp.0000181161.60638.fa.
    [8] ZEPP JA, MORRISEY EE. Cellular crosstalk in the development and regeneration of the respiratory system[J]. Nat Rev Mol Cell Biol, 2019, 20(9): 551-566. DOI: 10.1038/s41580-019-0141-3.
    [9] XU X, XU JF, ZHENG G, et al. CARD9S12N facilitates the production of IL-5 by alveolar macrophages for the induction of type 2 immune responses[J]. Nat Immunol, 2018, 19(6): 547-560. DOI: 10.1038/s41590-018-0112-4.
    [10] CAI T, QIU J, JI Y, et al. IL-17-producing ST2+ group 2 innate lymphoid cells play a pathogenic role in lung inflammation[J]. J Allergy Clin Immunol, 2019, 143(1): 229-244. DOI: 10.1016/j.jaci.2018.03.007.
    [11] LI W, BRIBRIESCO AC, NAVA RG, et al. Lung transplant acceptance is facilitated by early events in the graft and is associated with lymphoid neogenesis[J]. Mucosal Immunol, 2012, 5(5): 544-554. DOI: 10.1038/mi.2012.30.
    [12] YAMADA Y, BRÜSTLE K, JUNGRAITHMAYR W. T helper cell subsets in experimental lung allograft rejection[J]. J Surg Res, 2019, 233: 74-81. DOI: 10.1016/j.jss.2018.07.073.
    [13] 练巧燕, 陈奥, 徐鑫, 等. 肺移植术后稳定状态受者T淋巴细胞亚群的动态变化分析[J]. 器官移植, 2021, 12(1): 83-89. DOI: 10.3969/j.issn.1674-7445.2021.01.013.

    LIAN QY, CHEN A, XU X, et al. Analysis on dynamic changes of T lymphocyte subsets in recipients with stable graft status after lung transplantation[J]. Organ Transplant, 2021, 12(1): 83-89. DOI: 10.3969/j.issn.1674-7445.2021.01.013.
    [14] COIFFARD B, PELARDY M, LOUNDOU AD, et al. Effect of immunosuppression on target blood immune cells within 1 year after lung transplantation: influence of age on T lymphocytes[J]. Ann Transplant, 2018, 23: 11- 24. DOI: 10.12659/aot.906372.
    [15] SPECK NE, SCHUURMANS MM, BENDEN C, et al. Plasma and bronchoalveolar lavage samples in acute lung allograft rejection: the potential role of cytokines as diagnostic markers[J]. Respir Res, 2017, 18(1): 151. DOI: 10.1186/s12931-017-0634-6.
    [16] HODGE G, HODGE S, AHERN J, et al. Up-regulation of alternate co-stimulatory molecules on proinflammatory CD28null T cells in bronchiolitis obliterans syndrome[J]. Clin Exp Immunol, 2013, 173(1): 150-160. DOI: 10.1111/cei.12081.
    [17] NOSOTTI M, TARSIA P, MORLACCHI LC. Infections after lung transplantation[J]. J Thorac Dis, 2018, 10(6): 3849-3868. DOI: 10.21037/jtd.2018.05.204.
    [18] HOOVER J, MINTZ MA, DEITER F, et al. Rapid molecular detection of airway pathogens in lung transplant recipients[J]. Transpl Infect Dis, 2021, 23(4): e13579. DOI: 10.1111/tid.13579.
    [19] PERMPALUNG N, SAIT AS, BAZEMORE K, et al. Human metapneumovirus and parainfluenza virus infections in lung transplant recipients: the effects on lung allograft and clinical outcomes[J]. Transplantation, 2021, DOI: 10.1097/TP.0000000000003645[Epubaheadofprint].
    [20] GARDINER BJ, LEE SJ, CRISTIANO Y, et al. Evaluation of Quantiferon®-Monitor as a biomarker of immunosuppression and predictor of infection in lung transplant recipients[J]. Transpl Infect Dis, 2021, 23(3): e13550. DOI: 10.1111/tid.13550.
    [21] WU B, HUANG M, JIAO G, et al. Lung transplantation during the outbreak of coronavirus disease 2019 in China[J]. J Thorac Cardiovasc Surg, 2020, DOI: 10.1016/j.jtcvs.2020.10.154[Epubaheadofprint].
    [22] HAWKINS RB, MEHAFFEY JH, CHARLES EJ, et al. Lung transplantation for severe post-coronavirus disease 2019 respiratory failure[J]. Transplantation, 2021, 105(6): 1381- 1387. DOI: 10.1097/TP.0000000000003706.
    [23] KAUL DR, VALESANO AL, PETRIE JG, et al. Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing[J]. Am J Transplant, 2021, 21(8): 2885-2889. DOI: 10.1111/ajt.16532.
    [24] LIU M, WORLEY S, MALLORY GB JR, et al. Fungal infections in pediatric lung transplant recipients: colonization and invasive disease[J]. J Heart Lung Transplant, 2009, 28(11): 1226-1230. DOI: 10.1016/j.healun.2009.06.006.
    [25] PENNINGTON KM, YOST KJ, ESCALANTE P, et al. Antifungal prophylaxis in lung transplant: a survey of United States' transplant centers[J]. Clin Transplant, 2019, 33(7): e13630. DOI: 10.1111/ctr.13630.
    [26] RAMMAERT B, PUYADE M, CORNELY OA, et al. Perspectives on scedosporium species and lomentospora prolificans in lung transplantation: results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts, and European Confederation of Medical Mycology[J]. Transpl Infect Dis, 2019, 21(5): e13141. DOI: 10.1111/tid.13141.
    [27] DIAMOND JM, PORTEOUS MK, CANTU E, et al. Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantation[J]. PLoS One, 2012, 7(12): e51932. DOI: 10.1371/journal.pone.0051932.
    [28] MORRISON MI, PITHER TL, FISHER AJ. Pathophysiology and classification of primary graft dysfunction after lung transplantation[J]. J Thorac Dis, 2017, 9(10): 4084-4097. DOI: 10.21037/jtd.2017.09.09.
    [29] TESTELMANS D, SCHOOVAERTS K, BELGE C, et al. Sleep-disordered breathing after lung transplantation: an observational cohort study[J]. Am J Transplant, 2021, 21(1): 281-290. DOI: 10.1111/ajt.16130.
    [30] 崔小川, 李琪, 周敏. 肺移植与阻塞性睡眠呼吸暂停[J]. 中华结核和呼吸杂志, 2021, 44(3): 257-260. DOI: 10.3760/cma.j.cn112147-20200606-00682.

    CUI XC, LI Q, ZHOU M, et al. Progress in the treatment of mycobacterium abscessus pulmonary disease[J]. Chin J Tuberc Respir Dis, 2021, 44(3): 257-260. DOI: 10.3760/cma.j.cn112147-20200606-00682.
    [31] RAVICHANDRAN R, BANSAL S, RAHMAN M, et al. The role of donor-derived exosomes in lung allograft rejection[J]. Hum Immunol, 2019, 80(8): 588-594. DOI: 10.1016/j.humimm.2019.03.012.
  • 加载中
图(1)
计量
  • 文章访问数:  828
  • HTML全文浏览量:  145
  • PDF下载量:  82
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-08-03
  • 刊出日期:  2021-11-15

目录

    /

    返回文章
    返回